v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
 9 Months Ended
Apr. 30, 2026
Apr. 30, 2025
Cash flows from operating activities:    
Net loss $ (32,967,000) $ (163,212,000)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization of property, plant and equipment 9,094,000 8,400,000
Amortization of intangible assets 14,684,000 16,680,000
Amortization of stock-based compensation 2,720,000 2,520,000
Amortization of cost to fulfill assets 0 261,000
Paid-in-kind interest under term loan 0 5,528,000
Amortization of deferred financing costs, debt discount and accreted interest related to subordinated credit facility 16,245,000 4,451,000
Amortization of deferred financing costs and debt discount related to credit facility 4,108,000 3,496,000
Write-off of deferred financing costs and debt discounts 0 4,891,000
Change in fair value of warrants and derivatives (9,763,000) (15,450,000)
Loss on disposal of property, plant and equipment 52,000 310,000
(Benefit from) provision for allowance for doubtful accounts and contract assets (935,000) 17,716,000
Provision for excess and obsolete inventory 1,553,000 14,485,000
Deferred income tax expense (benefit) 609,000 (584,000)
Impairment of long-lived assets, including goodwill 0 79,555,000
Changes in assets and liabilities:    
Accounts receivable 17,977,000 26,407,000
Inventories 5,574,000 960,000
Prepaid expenses and other current assets (3,266,000) (552,000)
Other assets (28,000) (1,609,000)
Accounts payable (3,660,000) (13,930,000)
Accrued expenses and other current liabilities (3,916,000) (5,243,000)
Contract liabilities (363,000) (2,297,000)
Other liabilities, non-current 500,000 34,000
Interest payable (14,000) (1,067,000)
Income taxes payable 850,000 (1,489,000)
Net cash provided by (used in) operating activities 19,054,000 (19,739,000)
Cash flows from investing activities:    
Proceeds from sale of indefinite lived intangible asset 13,000 0
Purchases of property, plant and equipment (13,119,000) (6,529,000)
Net cash used in investing activities (13,106,000) (6,529,000)
Cash flows from financing activities:    
Proceeds from subordinated credit facility 0 65,000,000
Payments under revolving loan (14,000,000) (9,084,000)
Repayment of term loan (3,038,000) (27,252,000)
Proceeds from issuance of employee stock purchase plan shares 77,000 101,000
Payment of deferred financing costs 0 (4,220,000)
Remittance of employees’ statutory tax withholding for stock awards (463,000) (1,186,000)
Payment of shelf registration costs 12,000 207,000
Cash dividends paid on common stock (32,000) (157,000)
Payment of convertible preferred stock amendment fees 0 (650,000)
Net cash (used in) provided by financing activities (17,468,000) 22,269,000
Net decrease in cash and cash equivalents (11,520,000) (3,999,000)
Cash and cash equivalents at beginning of period 40,019,000 32,433,000
Cash and cash equivalents at end of period 28,499,000 28,434,000
Cash paid during the period for:    
Interest 13,946,000 21,019,000
Income taxes, net (41,000) 1,396,000
Non-cash investing and financing activities:    
Adjustment to reflect redemption value of convertible preferred stock 21,238,000 76,785,000
Term loan amendment fee paid-in-kind 2,809,000 4,654,000
Accrued term loan amendment fee 0 2,809,000
Accrued additions to property, plant and equipment 584,000 263,000
Accrued shelf registration costs 225,000 10,000
Accrued deferred financing costs 0 6,000
Issuance of restricted stock 15,000 6,000
Accrued remittance of employees' statutory tax withholdings 39,000 1,000
Reversal of dividend equivalents 0 (33,000)
Convertible Preferred Stock    
Cash flows from financing activities:    
Payment of convertible preferred stock issuance costs $ 0 $ (76,000)